CD70-有针对性的无线电静音学:现在和未来
Binyu Shi1, Xinyuan Zhou1, Junjun Zhou2
1Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Seminars in nuclear medicine
|September 19, 2025
概括
70分化集群 (CD70) 在癌症中过度表达. 针对CD70的放射性疗法对癌症治疗有前途,解决了当前治疗方法的局限性,如抗体-药物合物和CAR-T细胞.
科学领域:
- 在瘤学瘤学.
- 放射化学 放射化学是指辐射化学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 分化集群70 (CD70) 是TNF超级家族成员,在ccRCC和NPC等恶性瘤中过度表达.
- CD70作为共刺激受体CD27的连接体起作用.
- 目前的疗法 (ADC,CAR-T) 面临着诸如耐药性和瘤透率差等挑战.
研究的目的:
- 审查正常和瘤组织中的CD70表达.
- 为了突出CD70向的免疫PET/CT成像结果.
- 讨论治疗性放射性药物对于未来的CD70向辐射疗法开发.
主要方法:
- 关于CD70表达的文献综述.
- 对免疫-PET/CT成像的临床试验数据的分析.
- 对临床前和临床治疗放射性药物的调查.
主要成果:
- CD70在各种癌症中异常表达.
- 临床试验显示CD70向免疫PET/CT成像的有希望的结果.
- 一些治疗性放射性药物正在开发中.
结论:
- 针对CD70的放射性射剂为当前治疗的局限性提供了潜在的解决方案.
- 免疫-PET/CT成像证明了临床实用性.
- 为了临床应用,有必要进一步开发放射性疗法.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:56Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K